{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T13:55:24Z","timestamp":1761400524912},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1007\/s11910-007-0022-6","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T17:36:41Z","timestamp":1176917801000},"page":"57-62","source":"Crossref","is-referenced-by-count":43,"title":["Guillain-Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"7","author":[{"given":"Satoshi","family":"Kuwabara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,16]]},"reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","volume":"39","author":"J.W. Griffin","year":"1996","unstructured":"Griffin JW, Li CY, Ho TW, et al.: Pathology of the motorsensory axonal Guillain-Barr\u00e9 syndrome. Ann Neurol 1996, 39:17\u201328.","journal-title":"Ann Neurol"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","volume":"64","author":"S. Kuwabara","year":"2004","unstructured":"Kuwabara S: Guillain-Barr\u00e9 syndrome. Epidemiology, pathophysiology and management. Drugs 2004, 64:597\u2013610.","journal-title":"Drugs"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"R.A. Hughes","year":"2005","unstructured":"Hughes RA, Corblath DR: Guillain-Barr\u00e9 syndrome. Lancet 2005, 366:1653\u20131666.","journal-title":"Lancet"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"T.W. Ho","year":"1995","unstructured":"Ho TW, Mishu B, Li CY, et al.: Guillain-Barr\u00e9 syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995, 118:597\u2013605.","journal-title":"Brain"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","volume":"48","author":"K. Ogawara","year":"2000","unstructured":"Ogawara K, Kuwabara S, Mori M, et al.: Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000, 48:624\u2013631.","journal-title":"Ann Neurol"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.coi.2005.09.004","volume":"17","author":"N. Yuki","year":"2005","unstructured":"Yuki N: Carbonhydrate mimicry: a new paradigm of autoimmune diseases. Curr Opin Immunol 2005, 17:577\u2013582.","journal-title":"Curr Opin Immunol"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"R.D. Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA, et al.: Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Ann Neurol 1998, 44:780\u2013788.","journal-title":"Ann Neurol"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"B.C. Jacobs","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FG, et al.: The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome. A case control study. Neurology 1998, 51:1110\u20131115.","journal-title":"Neurology"},{"issue":"Suppl","key":"22_CR9","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","volume":"175","author":"R.A. Hughes","year":"1997","unstructured":"Hughes RA, Rees JH: Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome. J Infect Dis 1997, 175(Suppl): S92\u2013S100.","journal-title":"J Infect Dis"},{"key":"22_CR10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000133205.05169.04","volume":"63","author":"S. Kuwabara","year":"2004","unstructured":"Kuwabara S, Ogawara K, Misawa S, et al.: Does Campylobacter jejuni infection elicit \u201cdemyelinating\u201d Guillain-Barr\u00e9 syndrome? Neurology 2004, 63:529\u2013533.","journal-title":"Neurology"},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","volume":"101","author":"N. Yuki","year":"2004","unstructured":"Yuki N, Susuki K, Koga M, et al.: Carbonhydrate mimicry between human ganglioside GM1 asnd Campylobacter jejuni lipooligosaccharide causes Guillain-Barr\u00e9 syndrome. Proc Natl Acad Sci USA 2004, 101:11404\u201311409.","journal-title":"Proc Natl Acad Sci USA"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","volume":"49","author":"N. Yuki","year":"2001","unstructured":"Yuki N, Yamada M, Koga M, et al.: Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001, 49:712\u2013720.","journal-title":"Ann Neurol"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.33333","volume":"54","author":"K. Susuki","year":"2003","unstructured":"Susuki K, Nishimoto Y, Yamada M, et al.: Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol 2003, 54:383\u2013388.","journal-title":"Ann Neurol"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1074\/jbc.M108452200","volume":"277","author":"M. Gilbert","year":"2002","unstructured":"Gilbert M, Karwaski MF, Bernatchez S, et al.: The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni: biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem 2002, 277:327\u2013337.","journal-title":"J Biol Chem"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI200415707","volume":"14","author":"P.C. Godschalk","year":"2004","unstructured":"Godschalk PC, Heikema AP, Gilbert M, et al.: The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barr\u00e9 syndrome. J Clin Invest 2004, 14:1659\u20131665.","journal-title":"J Clin Invest"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1212\/01.wnl.0000176914.70893.14","volume":"65","author":"M. Koga","year":"2005","unstructured":"Koga M, Takahashi M, Masuda M, et al.: Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barr\u00e9 syndrome. Neurology 2005, 65:1376\u20131381.","journal-title":"Neurology"},{"key":"22_CR17","first-page":"265","volume":"5","author":"Y. Olsson","year":"1990","unstructured":"Olsson Y: Microenvironment of the peripheral nervous system under normal and pathological conditions. Crit Rev Neurobiol 1990, 5:265\u2013311.","journal-title":"Crit Rev Neurobiol"},{"key":"22_CR18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mus.880160304","volume":"16","author":"M. Bromberg","year":"1993","unstructured":"Bromberg M, Albers JW: Patterns of sensory nerve conduction abnormalities in demyelinating anad axonal peripheral nerve disorders. Muscle Nerve 1993, 16:262\u2013266.","journal-title":"Muscle Nerve"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jnnp.72.1.37","volume":"72","author":"S. Kuwabara","year":"2002","unstructured":"Kuwabara S, Ogawara K, Misawa S, et al.: Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002, 72:37\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"22_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000078485","volume":"51","author":"S. Kuwabara","year":"2004","unstructured":"Kuwabara S, Ogawara K, Misawa S, et al.: Sensory nerve conduction in demyelinating and axonal Guillain-Barr\u00e9 syndromes. Eur Neurol 2004, 51:196\u2013198.","journal-title":"Eur Neurol"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","volume":"44","author":"S. Kuwabara","year":"1998","unstructured":"Kuwabara S, Yuki N, Koga M, et al.: IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barr\u00e9 syndrome. Ann Neurol 1998, 44:202\u2013208.","journal-title":"Ann Neurol"},{"key":"22_CR22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1212\/01.WNL.0000153071.71335.E9","volume":"64","author":"A. Hiraga","year":"2005","unstructured":"Hiraga A, Kuwabara S, Ogawara K, et al.: Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barr\u00e9 syndrome. Neurology 2005, 64:856\u2013860.","journal-title":"Neurology"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ana.10275","volume":"52","author":"S. Kuwabara","year":"2002","unstructured":"Kuwabara S, Ogawara K, Sung JY, et al.: Differences in membrane properties of axonal and demyelinating Guillain-Barr\u00e9 syndromes. Ann Neurol 2002, 52:180\u2013187.","journal-title":"Ann Neurol"},{"key":"22_CR24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mus.10488","volume":"28","author":"S. Kuwabara","year":"2003","unstructured":"Kuwabara S, Bostock H, Ogawara K, et al.: The refractory period of transmission is impaired in axonal Guillain-Barr\u00e9 syndrome. Muscle Nerve 2003, 28:683\u2013689.","journal-title":"Muscle Nerve"},{"key":"22_CR25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.20395","volume":"57","author":"M.C. Kiernan","year":"2005","unstructured":"Kiernan MC, Isbister GK, Lin CS, et al.: Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005, 57:339\u2013348.","journal-title":"Ann Neurol"},{"key":"22_CR26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0896-6273(01)00306-3","volume":"30","author":"L. Pedraza","year":"2001","unstructured":"Pedraza L, Huang J, Colman DR: Organizing principles of the axoglial apparatus. Neuron 2001, 30:335\u2013344.","journal-title":"Neuron"},{"key":"22_CR27","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1073\/pnas.98.3.1235","volume":"98","author":"C.V. Melendez-Vasquez","year":"2001","unstructured":"Melendez-Vasquez CV, Rios J, Zanazzi G, et al.: Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes. Proc Natl Acad Sci U S A 2001, 98:1235\u20131240.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1523\/JNEUROSCI.22-15-06507.2002","volume":"22","author":"T. Ishubashi","year":"2002","unstructured":"Ishubashi T, Dupree JL, Ikenaka K, et al.: A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J Neurosci 2002, 22:6507\u20136514.","journal-title":"J Neurosci"},{"key":"22_CR29","doi-asserted-by":"crossref","unstructured":"Hughes RA, Swan AV, van Koningsveld R, et al.: Corticosteroids for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev 2006, 19:CD001446.","DOI":"10.1002\/14651858.CD001446.pub2"},{"key":"22_CR30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.1016","volume":"50","author":"M.M. Rich","year":"2001","unstructured":"Rich MM, Pinter MJ: Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001, 50:26\u201333.","journal-title":"Ann Neurol"},{"key":"22_CR31","doi-asserted-by":"crossref","unstructured":"Raphael JC, Chevret S, Hughes RA, et al.: Plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev 2001, CD001798.","DOI":"10.1002\/14651858.CD001798"},{"key":"22_CR32","doi-asserted-by":"crossref","unstructured":"Hughes RA, Raphael JC, Swan AV, et al.: Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev 2004, CD002063.","DOI":"10.1002\/14651858.CD002063.pub2"},{"key":"22_CR33","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","volume":"56","author":"R.D. Hadden","year":"2001","unstructured":"Hadden RD, Karch H, Hartung HP, et al.: Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome. Neurology 2001, 56:758\u2013765.","journal-title":"Neurology"},{"key":"22_CR34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/1097-4598(200101)24:1<54::AID-MUS6>3.0.CO;2-9","volume":"24","author":"S. Kuwabara","year":"2001","unstructured":"Kuwabara S, Mori M, Ogawara K, et al.: Intravenous immunoglobulin therapy for Guillain-Barr\u00e9 syndrome with IgG anti-GM1 antibody. Muscle Nerve 2001, 24:54\u201358.","journal-title":"Muscle Nerve"},{"key":"22_CR35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1212\/WNL.57.5.774","volume":"57","author":"K.H. Wollinsky","year":"2002","unstructured":"Wollinsky KH, Hulser PJ, Brinkmeier H, et al.: CFS filtration is an effective treatment of Guillain-Barr\u00e9 syndrome: a randomized clinical trial. Neurology 2002, 57:774\u2013780.","journal-title":"Neurology"},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000050798","volume":"46","author":"B. Schaller","year":"2001","unstructured":"Schaller B, Radziwill AJ, Steck AJ: Successful treatment of Guillain-Barr\u00e9 syndrome with combined administration of Interferon-b-1a and intravenous immunoglobulin. Eur Neurol 2001, 46:167\u2013168.","journal-title":"Eur Neurol"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mus.10019","volume":"25","author":"K. Miyamoto","year":"2002","unstructured":"Miyamoto K, Oka N, Kawasaki T, et al.: New cyclooxygenase-2-inhibitors for treatment of experimental autoimmune neuritis. Muscle Nerve 2002, 25:280\u2013282.","journal-title":"Muscle Nerve"},{"key":"22_CR38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh328","volume":"128","author":"D.A. Bechtold","year":"2005","unstructured":"Bechtold DA, Yue X, Evans RM, et al.: Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecanamide. Brain 2005, 128:18\u201328.","journal-title":"Brain"},{"key":"22_CR39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.64.1.74","volume":"64","author":"J.H. Rees","year":"1998","unstructured":"Rees JH, Thompson RD, Smeeton NC, et al.: Epidemiological study of Guillain-Barr\u00e9 syndrome in south east England. J Neurol Neurosurg Psychiatry 1998, 64:74\u201377.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-007-0022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-007-0022-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-007-0022-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:24:37Z","timestamp":1559435077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-007-0022-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11910-007-0022-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}